Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Qingdao Haier Biomedical Co.,Ltd

Capitalization 9.79B 1.42B 1.22B 1.1B 1.06B 1.92B 131B 2.01B 13.03B 5.23B 62.45B 5.32B 5.21B 224B P/E ratio 2025
39.7x
P/E ratio 2026 * 18.4x
Enterprise value 9.79B 1.42B 1.22B 1.1B 1.06B 1.92B 131B 2.01B 13.03B 5.23B 62.45B 5.32B 5.21B 224B EV / Sales 2025
4.26x
EV / Sales 2026 * 3.15x
Free-Float
49.58%
Yield 2025 *
-
Yield 2026 * -
1 day-0.51%
1 week-4.14%
Current month-4.14%
1 month-2.84%
3 months-1.62%
6 months-6.00%
Current year-0.91%
1 week 30.92
Extreme 30.92
32.56
1 month 30.92
Extreme 30.92
33.29
Current year 30.92
Extreme 30.92
38.8
1 year 29.68
Extreme 29.68
38.8
3 years 23.96
Extreme 23.96
75.5
5 years 23.96
Extreme 23.96
150.88
10 years 23.87
Extreme 23.87
150.88
Manager TitleAgeSince
Chief Executive Officer 56 27/10/2005
Director of Finance/CFO 45 31/12/2018
Corporate Officer/Principal 54 31/12/2018
Director TitleAgeSince
Director/Board Member 56 27/10/2005
Chairman 56 31/05/2018
Director/Board Member 59 31/05/2018
Change 5d. change 1-year change 3-years change Capi.($)
-0.51%-4.14%-8.27%-53.46% 1.43B
+0.20%-1.40%-4.81%-9.36% 186B
-0.27%-1.96%+0.81%+112.85% 174B
+0.85%-4.65%-4.29%-19.37% 138B
+0.78%-5.96%-23.85%+52.32% 106B
-1.01%-3.31%-22.99%-21.78% 52.29B
+2.45%-4.42%+21.59%+9.59% 47.42B
-0.17%-2.07%+6.52%+18.83% 36.67B
+0.63%-7.10%-12.76%-2.51% 33.85B
+0.46%-2.34%-5.33%-16.93% 32.52B
Average +0.33%-4.83%-5.34%+7.02% 80.88B
Weighted average by Cap. +0.32%-4.94%-5.48%+24.79%

Financials

2025 2026 *
Net sales 2.63B 381M 328M 296M 284M 516M 35.06B 540M 3.5B 1.4B 16.77B 1.43B 1.4B 60.18B 3.1B 449M 387M 350M 335M 609M 41.38B 637M 4.13B 1.66B 19.79B 1.69B 1.65B 71.04B
Net income 442M 63.92M 55.14M 49.79M 47.72M 86.73M 5.89B 90.68M 588M 236M 2.82B 240M 235M 10.11B 545M 78.89M 68.05M 61.46M 58.9M 107M 7.27B 112M 726M 291M 3.48B 296M 290M 12.48B
Net Debt - -
Logo Qingdao Haier Biomedical Co.,Ltd
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
Employees
2,807
Date Price Change Volume
08/03/26 31.49 ¥ -0.51% 1,934,877
06/03/26 31.65 ¥ +1.77% 1,903,866
05/03/26 31.10 ¥ +0.26% 1,581,800
04/03/26 31.02 ¥ -1.05% 1,929,094
03/03/26 31.35 ¥ -2.91% 3,512,852
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
31.49
Average target price
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688139 Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW